tyramine has been researched along with n-(2-aminoethyl)-4-chlorobenzamide hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonetti, EP; Da Prada, M; Imhof, R; Keller, HH; Kettler, R | 1 |
| Da Prada, M; Keller, G; Keller, HH; Kettler, R | 1 |
2 other study(ies) available for tyramine and n-(2-aminoethyl)-4-chlorobenzamide hydrochloride
| Article | Year |
|---|---|
Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzamides; Brain; Corpus Striatum; Dopamine; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease, Secondary; Pyridines; Rats; Selegiline; Substantia Nigra; Tyramine | 1987 |
Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.
Topics: Animals; Benzamides; Brain; Brain Chemistry; Dialysis; In Vitro Techniques; Liver; Male; Moclobemide; Monoamine Oxidase Inhibitors; Piperidines; Rats; Tyramine | 1987 |